论文部分内容阅读
目的探讨不孕症患者的剩余胚胎继续培养成囊胚进行玻璃化冷冻复苏囊胚移植的临床结局。方法对2015年在我中心接受常规IVF-ET治疗不孕症130例患者剩余胚胎继续培养成囊胚进行玻璃化冷冻复苏移植后临床资料分析。结果133个周期中共冷冻复苏囊胚258枚,移植囊胚244枚,复苏存活率94.57%,临床妊娠率30.76%。结论采用玻璃化冷冻复苏囊胚技术可以提高一次取卵的总妊娠率,是治疗不孕症的重要组成部分。
Objective To investigate the clinical outcomes of the remaining embryos in infertility patients who have undergone vitrification and blastocyst transplantation. Methods The clinical data of 130 patients with infertility treated with conventional IVF-ET in our center during 2015 and the remaining embryos were further cultivated into vitrified embryos were analyzed retrospectively. Results In the 133 cycles, 258 cryopreserved blastocysts and 244 blastocysts were transplanted, the survival rate of recovery was 94.57% and the clinical pregnancy rate was 30.76%. Conclusion The vitrified blastocyst technique can increase the total pregnancy rate of one ovulation and is an important part of infertility treatment.